Chuanling Chen

Counselor


  230 Essex St Apt 21, Melrose
     Massachusetts, 02176-3125
  781-333-7043    781-333-7043 Maps & Directions
Chuanling Chen is a Melrose, Massachusetts based counselor who is specialized as Counselor. Her current practice location is 230 Essex St Apt 21, Melrose. Patients can book an appointment with her at 781-333-7043.
Chuanling Chen is a trained and licensed mental health professional who helps individuals, couples, or groups manage and overcome emotional, psychological, behavioral, or relationship challenges. She works with people dealing with anxiety, depression, mood disorders, trauma, post-traumatic stress disorder (PTSD), grief and loss etc. She support her clients by understanding their thoughts, emotions, and behaviors.
Complete Profile:
Chuanling Chen speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Chuanling Chen
Specialization: Counselor
Gender:Female
Accepts Medicare Assignment:No
Practice Address:230 Essex St Apt 21, Melrose,
Massachusetts, 02176-3125
Phone:781-333-7043
Fax:781-333-7043
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1306361308
NPI Enumeration Date: 10 Aug, 2017
NPI Last Update On: 10 Aug, 2017

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 230 Essex St Apt 21,
Melrose, Massachusetts
Zip: 02176-3125
Phone Number: 781-333-7043
Patients can reach Chuanling Chen at 230 Essex St Apt 21, Melrose, Massachusetts or can call to book an appointment on 781-333-7043.
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.

Comments/ Reviews: